Personal tools

Coexpression cluster:C331

From FANTOM5_SSTAR

Revision as of 17:38, 18 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C331_kidney_thyroid_breast_Adipocyte_adipose_retina_vagina



Phase1 CAGE Peaks

Hg19::chr11:60836185..60836188,-p@chr11:60836185..60836188
-
Hg19::chr14:104715586..104715589,+p@chr14:104715586..104715589
+
Hg19::chr5:150400145..150400158,+p1@GPX3
Hg19::chr5:150404893..150404902,+p4@GPX3
Hg19::chr5:150404904..150404928,+p@chr5:150404904..150404928
+
Hg19::chr5:150404932..150404941,+p@chr5:150404932..150404941
+
Hg19::chr5:150404956..150404977,+p@chr5:150404956..150404977
+
Hg19::chr5:150404964..150404982,-p@chr5:150404964..150404982
-
Hg19::chr5:150404991..150405006,+p@chr5:150404991..150405006
+
Hg19::chr5:150406455..150406487,+p3@GPX3
Hg19::chr5:150406486..150406500,-p@chr5:150406486..150406500
-
Hg19::chr5:150406528..150406537,+p@chr5:150406528..150406537
+
Hg19::chr5:150406539..150406588,-p@chr5:150406539..150406588
-
Hg19::chr5:150406546..150406555,+p@chr5:150406546..150406555
+
Hg19::chr5:150407007..150407019,+p@chr5:150407007..150407019
+
Hg19::chr5:150407015..150407023,-p@chr5:150407015..150407023
-
Hg19::chr5:150407045..150407060,+p@chr5:150407045..150407060
+
Hg19::chr5:150407573..150407582,+p@chr5:150407573..150407582
+
Hg19::chr5:150407683..150407708,-p4@CU690655
Hg19::chr5:150407695..150407704,+p@chr5:150407695..150407704
+
Hg19::chr5:150407726..150407744,-p3@CU690655
Hg19::chr5:150407728..150407739,+p@chr5:150407728..150407739
+
Hg19::chr5:150407741..150407750,+p@chr5:150407741..150407750
+
Hg19::chr5:150407760..150407799,-p1@CU690655
Hg19::chr5:150407800..150407825,-p2@CU690655
Hg19::chr5:150407829..150407840,+p@chr5:150407829..150407840
+
Hg19::chr5:150407857..150407891,+p@chr5:150407857..150407891
+
Hg19::chr5:150407894..150407949,+p@chr5:150407894..150407949
+
Hg19::chr5:150407957..150408028,+p@chr5:150407957..150408028
+
Hg19::chr5:150408069..150408081,+p@chr5:150408069..150408081
+
Hg19::chr5:150408124..150408137,+p@chr5:150408124..150408137
+
Hg19::chr5:150408168..150408181,-p5@CU690655
Hg19::chr5:150408185..150408218,+p@chr5:150408185..150408218
+
Hg19::chr5:150408223..150408268,-p@chr5:150408223..150408268
-
Hg19::chr5:150408230..150408259,+p@chr5:150408230..150408259
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006982response to lipid hydroperoxide0.00123631225715295
GO:0033194response to hydroperoxide0.00123631225715295
GO:0043295glutathione binding0.00123631225715295
GO:0051289protein homotetramerization0.0024726245143059
GO:0042744hydrogen peroxide catabolic process0.0024726245143059
GO:0042743hydrogen peroxide metabolic process0.0024726245143059
GO:0004602glutathione peroxidase activity0.0024726245143059
GO:0051262protein tetramerization0.0024726245143059
GO:0006749glutathione metabolic process0.0024726245143059
GO:0042542response to hydrogen peroxide0.0024726245143059
GO:0000302response to reactive oxygen species0.0030345846311936
GO:0051260protein homooligomerization0.00422406687860591
GO:0006800oxygen and reactive oxygen species metabolic process0.00427954242860636
GO:0008430selenium binding0.00441540091840339
GO:0051259protein oligomerization0.00487252477819103
GO:0004601peroxidase activity0.00487252477819103
GO:0016684oxidoreductase activity, acting on peroxide as acceptor0.00487252477819103
GO:0006790sulfur metabolic process0.00590682522861964
GO:0006979response to oxidative stress0.00780828793991336
GO:0042277peptide binding0.0128576474743907
GO:0005625soluble fraction0.0137760508654186
GO:0006732coenzyme metabolic process0.0161844513663659
GO:0006461protein complex assembly0.0176689626751442
GO:0051186cofactor metabolic process0.0176689626751442
GO:0008134transcription factor binding0.021363475803603
GO:0005615extracellular space0.0251066489144907
GO:0042221response to chemical stimulus0.0269699229430773
GO:0065003macromolecular complex assembly0.0333804309431296
GO:0044248cellular catabolic process0.0335040621688449
GO:0022607cellular component assembly0.0335040621688449
GO:0000267cell fraction0.035157629812787
GO:0044421extracellular region part0.035157629812787
GO:0009056catabolic process0.0364524795821157
GO:0006950response to stress0.0444345170070854



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.